Analyst Scoreboard: 10 Ratings For Thermo Fisher Scientific
Portfolio Pulse from Benzinga Insights
Analysts have provided a range of ratings for Thermo Fisher Scientific (NYSE:TMO) over the past quarter, with the majority being bullish. The average 12-month price target has increased to $634.5, up from $602.89. Key financial metrics indicate strong profitability and effective cost management despite a recent decline in revenue growth.
June 03, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have shown a predominantly bullish sentiment towards Thermo Fisher Scientific (NYSE:TMO) with an increased average price target of $634.5. The company's strong financial metrics, including high net margin and ROE, suggest robust profitability despite a recent revenue decline.
The majority of analysts have given bullish ratings, and the average price target has increased, indicating positive sentiment. Strong financial metrics such as high net margin and ROE further support a positive outlook despite a recent revenue decline.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100